Skip to main content
Clinical Trials/NCT03147846
NCT03147846
Completed
Not Applicable

The Hematologic Impact of Umbilical Cord Milking Versus Deferred Cord Clamping in Premature Neonates. A Randomized Controlled Trial

Zagazig University1 site in 1 country200 target enrollmentJune 8, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delayed Cord Clamping
Sponsor
Zagazig University
Enrollment
200
Locations
1
Primary Endpoint
hematological parameters of the premature neonates
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Comparing the beneficial effect of cord milking versus deferred cord clamping in preterm neonates. A randomized controlled trial

Detailed Description

Placental transfusion either by deferred cord clamping or umbilical cord milking became standard care and recommended management especially in preterm deliveries.1 In average, about 80 ml of blood was found to be transferred to the neoborn by one minute after birth.2 This additional blood can afford extra iron and blood volume giving the benefit of less iron deficiency anemia during the first year of life, less need for blood transfusion, less need for vasopressors and less intraventricular hemorrhage (IVH) by 50%.3 Placental transfusion with different techniques proved safety with no significant risks regarding postpartum hemorrhage, polycythemia, jaundice, Apgar score or admission rates.4 Our study aims to compare delayed cord clamping with umbilical cord milking as the best way for placental transfusion for preterm neonates.

Registry
clinicaltrials.gov
Start Date
June 8, 2017
End Date
September 1, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hytham Atia

lecturer

Zagazig University

Eligibility Criteria

Inclusion Criteria

  • Gestational age 24 to 34+6 weeks

Exclusion Criteria

  • Category III CTG
  • Monochorionic twins
  • Significant antepartum hemorrhage
  • IUGR or Rh incompatibility

Outcomes

Primary Outcomes

hematological parameters of the premature neonates

Time Frame: 12 months

first draw and peak hematocrit value and hemoglobin percent, need for inotropes and blood transfusion

Secondary Outcomes

  • composite neonatal morbidities(12 month)

Study Sites (1)

Loading locations...

Similar Trials